Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model - Morales-Cano, Daniel; Izquierdo-García, Jose Luis; Barreira, Bianca; Esquivel-Ruiz, Sergio; Callejo, Maria; Pandolfi, Rachele; Villa-Valverde, Palmira; Rodríguez, Ignacio; Cogolludo, Angel; Ruiz-Cabello, Jesus; Perez-Vizcaino, Francisco; Moreno, Laura (Frontiers in Pharmacology, 2023)